Cancer immunogenomic approach to neoantigen discovery in a checkpoint blockade responsive murine model of oral cavity squamous cell carcinoma

Authors

Paul Zolkind, Washington University School of Medicine in St. Louis
Dariusz Przybylski, Broad Institute of MIT and Harvard
Nemanja Marjanovic, Broad Institute of MIT and Harvard
Lan Nguyen, Broad Institute of MIT and Harvard
Tianxiang Lin, Washington University School of Medicine in St. Louis
Tanner Johanns, Washington University School of Medicine in St. Louis
Anton Alexandrov, Washington University School of Medicine in St. Louis
Liye Zhou, Dana-Farber Cancer Institute
Clint T. Allen, Johns Hopkins School of Medicine
Alexander P. Miceli, Washington University School of Medicine in St. Louis
Robert D. Schreiber, Washington University School of Medicine in St. Louis
Maxim Artyomov, Washington University School of Medicine in St. Louis
Gavin P. Dunn, Washington University School of Medicine in St. Louis
Ravindra Uppaluri, Brigham and Women's Hospital

Journal

Oncotarget

Publication Date

2018

Volume

9

Issue

3

Inclusive Pages

4109-4119

Document Type

Open Access Publication

DOI

10.18632/oncotarget.23751

Rights and Permissions

Zolkind, P., Przybylski, D., Marjanovic, N., Nguyen, L., Lin, T., Johanns, T., . . . Uppaluri, R. (2018). Cancer immunogenomic approach to neoantigen discovery in a checkpoint blockade responsive murine model of oral cavity squamous cell carcinoma. Oncotarget, 9(3), 4109-4119. doi:10.18632/oncotarget.23751.

Recommended Citation

Zolkind, Paul; Przybylski, Dariusz; Marjanovic, Nemanja; Nguyen, Lan; Lin, Tianxiang; Johanns, Tanner; Alexandrov, Anton; Zhou, Liye; Allen, Clint T.; Miceli, Alexander P.; Schreiber, Robert D.; Artyomov, Maxim; Dunn, Gavin P.; and Uppaluri, Ravindra, "Cancer immunogenomic approach to neoantigen discovery in a checkpoint blockade responsive murine model of oral cavity squamous cell carcinoma." Oncotarget. 9, 3. 4109-4119. (2018).
https://digitalcommons.wustl.edu/open_access_pubs/6468